The central role of PDR1 in the foundation of yeast drug resistance.

Vivienne Fardeau, Gaëlle Lelandais, Andrew Oldfield, Héle Ne Salin, Sophie Lemoine, Mathilde Garcia, Véronique Tanty, Stéphane Le Crom, Claude Jacq, Frédéric Devaux

The Journal of biological chemistry 2007 Feb 16

filter terms:

The widespread pleiotropic drug resistance (PDR) phenomenon is well described as the long term selection of genetic variants expressing constitutively high levels of membrane transporters involved in drug efflux. However, the transcriptional cascades leading to the PDR phenotype in wild-type cells are largely unknown, and the first steps of this phenomenon are poorly understood. We investigated the transcriptional mechanisms underlying the establishment of an efficient PDR response in budding yeast. We show that within a few minutes of drug sensing yeast elicits an effective PDR response, involving tens of PDR genes. This early PDR response (ePDR) is highly dependent on the Pdr1p transcription factor, which is also one of the major genetic determinants of long term PDR acquisition. The activity of Pdr1p in early drug response is not drug-specific, as two chemically unrelated drugs, benomyl and fluphenazine, elicit identical, Pdr1p-dependent, ePDR patterns. Our data also demonstrate that Pdr1p is an original stress response factor, the DNA binding properties of which do not depend on the presence of drugs. Thus, Pdr1p is a promoter-resident regulator involved in both basal expression and rapid drug-dependent induction of PDR genes.

Citation

Vivienne Fardeau, Gaëlle Lelandais, Andrew Oldfield, Héle Ne Salin, Sophie Lemoine, Mathilde Garcia, Véronique Tanty, Stéphane Le Crom, Claude Jacq, Frédéric Devaux. The central role of PDR1 in the foundation of yeast drug resistance. The Journal of biological chemistry. 2007 Feb 16;282(7):5063-5074